How many stocks does LOOMIS SAYLES & CO L P own?

As of Q2 2025, LOOMIS SAYLES & CO L P holds 722 positions in their 13F portfolio.

What is LOOMIS SAYLES & CO L P's largest holding?

NVDA at 8.3% of portfolio, worth $6.6B.

What is LOOMIS SAYLES & CO L P's total portfolio value?

$79.8B as of Q2 2025, tracked across 722 holdings.

Is LOOMIS SAYLES & CO L P a hedge fund?

LOOMIS SAYLES & CO L P is an institutional investment manager required to file SEC 13F reports. This includes hedge funds, mutual funds, pension funds, and other institutions managing over $100M.

How often does LOOMIS SAYLES & CO L P report?

13F filings are due quarterly, approximately 45 days after each quarter end.

How has LOOMIS SAYLES & CO L P's portfolio changed in Q2 2025?

View LOOMIS SAYLES & CO L P's latest portfolio changes, new positions, and exits for Q2 2025 on HoldingsIntel.

What is LOOMIS SAYLES & CO L P's investment strategy?

LOOMIS SAYLES & CO L P is classified as a Steady Compounder fund based on HoldingsIntel's Fund DNA analysis of 6 behavioral dimensions.

LOOMIS SAYLES & CO L P

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

$79.8B

AUM

722

Positions

Q2 2025

Filing

Rating · 2.5

Quarterly Portfolio Change

Activity profile

$ moved · Q2'25

New1%Increased34%Decreased65%Exited0%

Composition

Equity vs derivatives

Equity100%Puts0%Calls0%

Holding period

Avg 4.2 years

<1Q5%1-4Q10%1-2Y9%2Y+76%

Q2 2025 Summary

Active quarter - 104 new positions, 109 exits, 246 increased. Top move: REGN (INCREASED, conviction 59). Portfolio: $79.8B across 722 positions.

Portfolio Allocation

Top holdings by portfolio weight

NVDA8.31%

META6.97%

NFLX6.27%

AMZN5.30%

TSLA5.14%

ORCL4.64%

V4.01%

MSFT3.85%

GOOGL3.84%

BA3.76%

Other2.26%

Sector Breakdown

Portfolio allocation by GICS sector

Technology28.86%

Communication Services20.43%

Consumer Cyclical16.31%

Healthcare11.09%

Financial Services9.47%

Industrials8.80%

Consumer Defensive3.00%

Unknown0.73%

Basic Materials0.52%

Energy0.48%

Other0.31%

Fund DNA

Behavioral investing profile

Steady Compounder85%- primarily Technology, Communication Services, Consumer Cyclical

Compare DNA across all funds

Fund Rating

7-dimension quality assessment

Solid(2.5 / 5.0)

Track Record65

Conviction40

Concentration0

Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Top Winners

VST27Q held

VISTRA CORP

Avg $21.28 · $10.3M est. P&L

Est. P&L

+814.17%

AXON21Q held

AXON ENTERPRISE INC

Avg $107.37 · $119,487 est. P&L

Est. P&L

+662.42%

MTSI22Q held

MACOM TECH SOLUTIONS HLDGS I

Avg $23.68 · $61.6M est. P&L

Est. P&L

+499.97%

Top Losers

Upgrade to Pro to see the worst-performing positions.

View plans

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Holdings722 positions

Export CSV(Pro)

Activity:

Stock	Shares	Value	Weight	Price Trend	Avg Buy	Est. P&L	Held	Conviction
NVDA NVIDIA CORPORATION	42M	$6.6B	8.3%	—	$112.06	+40.75%	26 qtrssince 2019-Q1	Decreased 0
META META PLATFORMS INC	7.5M	$5.6B	7.0%	—	$138.14	+430.29%	27 qtrssince 2018-Q4	Decreased 0
NFLX NETFLIX INC.	3.7M	$5B	6.3%	—	$29.20	+353.11%	20 qtrssince 2020-Q3	Decreased 0
AMZN AMAZON COM INC	19.3M	$4.2B	5.3%	—	$108.77	+105.30%	27 qtrssince 2018-Q4	Decreased 0
TSLA TESLA INC	12.9M	$4.1B	5.1%	—	$209.24	+54.67%	20 qtrssince 2020-Q3	Decreased 0
ORCL ORACLE CORP	16.9M	$3.7B	4.6%	—	$41.42	+404.25%	27 qtrssince 2018-Q4	Decreased 0
V VISA INC	9M	$3.2B	4.0%	—	$131.28	+164.01%	27 qtrssince 2018-Q4	Decreased 0
MSFT MICROSOFT CORP	6.2M	$3.1B	3.8%	—	$98.79	+400.23%	27 qtrssince 2018-Q4	Decreased 0
GOOGL ALPHABET INC	17.4M	$3.1B	3.8%	—	$96.03	+85.62%	27 qtrssince 2018-Q4	Decreased 0
BA BOEING CO	14.3M	$3B	3.8%	—	$187.67	+14.33%	27 qtrssince 2018-Q4	Decreased 0
ADSK AUTODESK INC	5.8M	$1.8B	2.3%	—	$134.27	+127.25%	27 qtrssince 2018-Q4	Increased 55
DIS DISNEY WALT CO	14.3M	$1.8B	2.2%	—	$120.98	+0.44%	27 qtrssince 2018-Q4	Increased 55
CRM SALESFORCE INC	6.3M	$1.7B	2.1%	—	$175.12	+55.61%	22 qtrssince 2020-Q1	Increased 55
VRTX VERTEX PHARMACEUTICALS INC	3.8M	$1.7B	2.1%	—	$232.19	+90.06%	23 qtrssince 2019-Q4	Increased 56
SHOP SHOPIFY INC	14.6M	$1.7B	2.1%	—	$40.73	+179.06%	15 qtrssince 2021-Q4	Increased 55
MNST MONSTER BEVERAGE CORP NEW	26.5M	$1.7B	2.1%	—	$39.51	+56.18%	27 qtrssince 2018-Q4	Increased 55
REGN REGENERON PHARMACEUTICALS	1.9M	$1B	1.3%	—	$461.18	+12.66%	27 qtrssince 2018-Q4	Increased 59
ISRG INTUITIVE SURGICAL INC	1.7M	$939.1M	1.2%	—	$297.77	+79.23%	22 qtrssince 2020-Q1	Increased 51
SBUX STARBUCKS CORP	9.6M	$878.5M	1.1%	—	$65.09	+38.68%	27 qtrssince 2018-Q4	Increased 51
NVO ADR NOVO-NORDISK A S	12.6M	$868M	1.1%	—	$61.28	+10.56%	27 qtrssince 2018-Q4	Increased 51
Showing 20 of 722 results.702 more with Pro.PROUpgrade to see all →